Comparison between Corona Virus Disease 2019 and influenza A virus pneumonia: epidemiological and clinical characteristics/ 新型冠状病毒肺炎与甲型H1N1流感流行病学与临床特点的对比分析

Documents on Corona Virus Disease 2019 (COVID- 19) and H1N1 infectious disease were reviewed and the epidemiological and clinical characteristics are summarized, in order to provide reference for the prevention and treatment of both kinds of patients and for clinical diagnosis of H1N1 influenza that outbroke in 2019 Both COVID-19 and HIN1 influenza are of strong transmissibility Their clinical manifestations are not obvious and it is difficult to identify them, therefore resulting in large-scale outbreaks People are generally susceptible to COVID-19, especially the elderly and patients suffering from cardiovascular basic disease The clinical symptoms of hypoxia are not obvious, but it could develop into dyspnea in about a week, and CT shows that patchy ground glass shadow scattered under pleura occurs in the majority of patients with COVID-19 influenza, and specific antiviral drugs and vaccines are in active trials But patients with HIN1 influenza tend to be young, and dyspnea progresses in them rapidly Anti-virus drugs such as Oseltamivir are efficient and specific vaccine can be inoculated Under the situation of a global epidemic outbreak, the clinical and epidemic characteristics of HIN1 influenza were reviewed, which might help the front-line medical staff to better identify and diagnose COVID-19 influenza